A team from four institutes in Prague and one university in Heidelberg has prepared a compound of boron, hydrogen, carbon and cobalt that is capable of blocking the protein responsible for the virus multiplication that liquidates leucocytes in a way that completely differs from the existing medicines.
Besides, the compound blocks the protein even in case of mutated resistant viruses. Team head Ms Pavlína Řezáčová said it cannot be ruled out, however, that the virus will develop resistance to the compound in the future:
Czech Press Agency (click)
RSC: Chemistry World (click, more technical)